563
Participants
Start Date
April 30, 2013
Primary Completion Date
April 30, 2014
Study Completion Date
April 30, 2014
Placebo
Matching placebo tablet
Lumacaftor Plus Ivacaftor Combination
Fixed dose combination tablet
Ivacaftor
Film-coated tablet
Oakland
Sacramento
Aurora
Hartford
New Haven
Jacksonville
Miami
Indianapolis
Iowa City
Kansas City
Lexington
Portland
Worcester
Detroit
Grand Rapids
Minneapolis
Jackson
St Louis
Omaha
Morristown
New Brunswick
Albuquerque
Albany
Buffalo
New York
Rochester
Syracuse
Cleveland
Columbus
Toledo
Oklahoma City
Philadelphia
Pittsburgh
Charleston
Sioux Falls
Memphis
Nashville
Dallas
Fort Worth
Houston
San Antonio
Salt Lake City
Richmond
Seattle
Spokane
Milwaukee
Brisbane
Chermside
Herston
South Brisbane
Nedlands
Subiaco
Innsbruck
Wels
Brussels
Ghent
Leuven
Liège
Calgary
Edmonton
Vancouver
Montreal
København Ø
Marseille
Toulouse
Montpellier
Lille
Paris
Bordeaux
Munich
Frankfurt am Main
Giessen
Hanover
Bochum
Jena
Barcelona
Valencia
Bristol
London
Liverpool
Newcastle upon Tyne
Leeds
Vertex Pharmaceuticals Incorporated
INDUSTRY